Wells Fargo Starts Cybin Inc. (HELP) at Overweight Jul 27, 2026 06:57AM
Wells Fargo sees psychedelics market reaching $11B by 2035 Jul 27, 2026 06:55AM
H.C. Wainwright Reiterates Buy Rating on Helus Pharma (HELP) Jul 22, 2026 06:52AM
Helus Pharma (HELP) PT Lowered to $70 at H.C. Wainwright Jul 9, 2026 06:51AM
Helus Pharma (HELP) PT Lowered to $42 at Canaccord Jul 1, 2026 06:38AM


Jun 29, 2026 07:43AM Helus Pharma reports $148M net loss, closes $50M offering
Jun 25, 2026 09:52AM Helus Pharma closes $50M share offering at $4.85 per share
Jun 24, 2026 06:01AM Helus Pharma prices $50M share offering at $4.85 per share
Apr 28, 2026 07:32AM Helus Pharma partners with TARA Mind for veteran mental health outreach
Apr 20, 2026 08:15AM Helus Pharma supports White House executive order on psychedelics
Apr 20, 2026 08:01AM Helus Pharma names Eric So as interim CEO after leadership change
Apr 16, 2026 07:33AM Helus Pharma appoints Dr. Ken Kramer as senior VP of medical affairs
Apr 13, 2026 05:30AM TD Cowen Starts Helus Pharma (HELP) at Buy
Mar 5, 2026 10:03AM Jefferies Reiterates Buy Rating on Helus Pharma (HELP) following Phase 2 data; "add'l data is needed for the Street to have greater confidence"
Feb 2, 2026 12:56AM Jefferies Starts Helus Pharma (HELP) at Buy